• Fund Type: ETF
  • Objective: Eurozone
  • Asset Class: Equity
  • Geographic Focus: Eurozone

iShares STOXX Europe 50 UCITS ETF DE

+ Add to Watchlist

SX5PEX:GR

30.3300 EUR 0.1300 0.43%

As of 07:15:04 ET on 07/31/2014.

Snapshot for iShares STOXX Europe 50 UCITS ETF DE (SX5PEX)

Open: 30.5500 High - Low: 30.5700 - 30.2900 Primary Exchange: Xetra ETF
Volume: 0 52-Week Range: 27.0700 - 31.4600 Beta vs SX5R: 0.9607

ETF Chart for SX5PEX

No chart data available.
  • SX5PEX:GR 30.2900
  • 1D
  • 1M
  • 1Y
30.4600
Interactive SX5PEX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SX5PEX

iShares STOXX Europe 50 UCITS ETF (DE) is an open-end, UCITS compliant exchange traded fund incorporated in Germany. The fund aims to track the performance of the STOXX Europe 50 index. The fund distributes income received to shareholders.

Inception Date: 2001-01-03 Telephone: 49-89-427-29-5858
Managers: -
Web Site: de.ishares.com

Fundamentals for SX5PEX

NAV (on 2014-07-30) 30.4000
Assets (M) (on 2014-07-30) 589.8510
Shares out (M) 19.40
Market Cap (M) 588.40
% Premium 0.20
Average 52-Week % Premium 0.0547
Fund Leveraged N

Dividends for SX5PEX

Dividend Type Income
Dividend Frequency 3x a yr
Last Dividend Net (on 2014-06-16) 0.5271
Dividend Yield (ttm) 2.62%

Performance for SX5PEX

1-Month +0.33% 1-Year +16.24%
3-Month +2.32% 3-Year +10.12%
Year To Date +5.93% 5-Year +8.96%
Expense Ratio 0.52

Top Fund Holdings for SX5PEX

Filing Date: 07/29/2014
Name Position Value % of Total
Nestle SA 580,150 32,843,383 5.565%
Novartis AG 486,859 32,025,567 5.427%
HSBC Holdings PLC 3,430,645 27,634,374 4.682%
Roche Holding AG 126,409 27,627,184 4.681%
Total SA 427,608 22,329,690 3.784%
Royal Dutch Shell PLC 708,070 21,603,216 3.661%
BP PLC 3,312,909 20,270,888 3.435%
Sanofi 216,827 16,656,650 2.822%
Banco Santander SA 2,118,841 16,166,757 2.739%
GlaxoSmithKline PLC 878,995 15,760,226 2.670%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil